Learn more about ACUVUE® Abiliti lenses

There are actions you can take to manage myopia. Learn more about ACUVUE® Abiliti lenses for myopia management by completing the form.

Man holding up child

Submit the form to learn more about myopia management and Abiliti®

With your consent, we will use your information to send you information about our products and services tailored to your interests through email. You may withdraw your consent at any time. Please read our Privacy Policy.

Required fields are marked with an asterisk.

*

*

*

*

Are you interested in Abiliti® for your child or yourself?

*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Myopia: What you need to know

Myopia is more than nearsightedness or blurry distance vision.1

Here are important facts to know:

A progressive disease

Myopia is a chronic, progressive disease that leads to the eye growing too long.1-3

Blurry vision

The lengthening of the eye changes the eye’s ability to focus on distant objects, resulting in blurry vision.1

Potential blindness

Myopia may also lead to blindness later in life.4

Lifestyle impact

Lifestyle changes like more reading, homework, and spending less time outside, are contributing to more children than ever before developing myopia at an early age.5,6

Abiliti product shot

Take Charge of Myopia to Help Kids Be Their Best

Kids just want to be kids. But when a child has myopia, life comes with extra challenges. For many kids, wearing eyeglasses may introduce self-image concerns and discourage participation in sports and other physical activities.1,2 Johnson & Johnson Vision is proud to offer daytime freedom from glasses or contacts with ACUVUE® Abiliti® Overnight Therapeutic Lenses for Myopia Management.*,3

References:

*Also available for adult myopes
**The lenses are indicated for reducing refractive error up to 6.00D of myopia and up to 1.50D of astigmatism. Results may vary by patient and prescription level.
†Previously marketed under Menicon Z Night. Initial CE approval for Orthokeratology was granted in 2006
‡Compared to single-vision spectacles

1. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.
2. Donovan L, Sankaridurg P, Ho A et al Myopia progression rates in urban children wearing single vision spectacles. OVS 2012;89(1):27-32.
3. Pärssinen O, Kauppinen M. Risk factors for high myopia: a 22 year follow up study from childhood to adulthood. Acta Ophthalmologica. 2019;97(5):510-518.
4. Haarman AEG, Enthoven CA, Tideman JWL, et al The Complications of Myopia: A Review and Meta-Analysis. Invest Ophthalmol Vis Sci. 2020 Apr 9;61(4):49.
5. Huang HM, Chang DS, Wu PC. The Association between Near Work Activities and Myopia in Children-A Systematic Review and Meta-Analysis. PLoS One. 2015 Oct 20;10(10):e0140419.
6. Wu PC, Chen CT, Chang LC, Niu YZ, Chen ML, Liao LL, Rose K, Morgan IG. Increased Time Outdoors Is Followed by Reversal of the Long-Term Trend to Reduced Visual Acuity in Taiwan Primary School Students. Ophthalmology. 2020 Nov;127(11):1462-1469. doi: 10.1016/j.ophtha.2020.01.054.
7. Data on File 2023. Instructions For Use (FDA)
8. Data on File 2023. Menicon Initial CE approval 2006
9. JJV Data on File 2023. ACUVUE® Abiliti Overnight Therapeutic Lenses for Myopia Management Consolidated, Approved Claims List; U.S. Only Claims

PP2023ABLM4124 v2

Clear Vision For You

Not actual patients or healthcare professionals. For illustrative purposes only.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Johnson & Johnson Vision, Inc., its subsidiaries or affiliates.

No use of any Johnson & Johnson Vision, Inc. trademark, trade name, or trade dress in this site may be made without the prior written authorization of Johnson & Johnson Vision, Inc., except to identify the product or services of the company. Third party trademarks are the property of their respective owners.

This website and the information contained herein is intended for use by US residents only.

© Johnson & Johnson and its affiliates 2024